最有价值和最强大的制药、医疗器械和医疗服务品牌的2026年度报告（英）2026

Healthcare2026 The annual report on the most valuable and strongest pharma, medical devicesand healthcare services brands AboutBrand Finance Bridging the gap betweenMarketing and Finance Brand Finance was set up in 1996 with theaim of 'bridging the gap between marketingand finance'. For more than 25 years, wehave helped companies and organisationsof all types to connect their brands to thebottom line. Quantifying thefinancial value of brands We put thousands of the world’s biggestbrands to the test every year. Rankingbrands across all sectors and countries,we publish over 100 reports annually. Unique combinationof expertise The world'sleading brandvaluationconsultancy Our teams have experienceacross a wide range of disciplinesfrom marketing and market research,to brand strategy and visual identity,to tax and accounting. Priding ourselveson technical credibility Brand Finance, a chartered accountancyfirm regulated by the Institute of CharteredAccountants in England and Wales, is thefirst brand valuation consultancy to join theInternational Valuation Standards Council.Our experts crafted standards (ISO 10668and ISO 20671) and our methodology,certified by Austrian Standards, is officiallyapproved by the Marketing AccountabilityStandards Board. For business enquiries, please contact:enquiries@brandfinance.com For media enquiries, please contact:press@brandfinance.com +44 207 389 9400www.brandfinance.com Contents Foreword5David Haigh, Chairman & CEO, Brand Finance Valuation Analysis9Most Valuable Pharma Brands 202611Fastest Growing Brand Value:Amgen12Brands to Watch:Novo Nordisk vs Lilly13 Brand Strength Analysis14 Medical Devices17Brand Value & Strength Analysis18 Healthcare Services19Brand Value & Strength Analysis20 Chinese Pharma21Brand Value & Strength Analysis22 Brand Spotlight24Guangzhou Pharmaceutical25 Insight29The economics of trust: Why reputation is30the hard currency of healthcare and pharmaDr. Markus Renner, PhD, Chairman, International Brand& Reputation Community (INBREC) Pharma | Brand Value Ranking (USDm)33 Medical Devices | Brand Value Ranking (USDm)34 Healthcare Services | Brand Value Ranking (USDm) Healthcare brandsnavigate innovation,regulation, andpricing pressures +Pharmaceutical leaders of 2026:Johnson & Johnson, Lilly, andRochehold top spots +Amgen accelerates brand value growth throughdiversification and pipeline strength +LillyvsNovo: A tale of shifting fortunes inweight-loss brands +Johnson & Johnsonis the strongest pharmaceuticalbrand globally, whileSamsung BiologicsandTong RenTanglead in their home markets +Medtronicextends medical devices lead throughinnovation-led growth +UnitedHealthcareretains healthcare servicesleadership amid heightened scrutiny +Guangzhou Pharmaceuticalstands out asfastest-growing Chinese pharmaceutical brand Foreword This year marks Brand Finance’s 30thanniversary. Throughout our history as acompany, there has been one enduring truism: brands operate in a world shapedby continual change. Rapid advancements in AI, geopolitical fragmentation, economic uncertainty,and rising expectations of corporate behaviour have all placed new pressureson organisations. While the challenges have evolved, the importance of buildingand maintaining brand strength has remained constant. Looking back to 1996, the global brand landscape was dominated by traditionalconsumer names. Since then, the rise of technology and digital services, the movefrom products to ecosystems, the increasing prominence of B2B brands, and thegrowth of place branding have fundamentally reshaped how value is created. David HaighChairman & CEO,Brand Finance Today, the commercial contribution of a strong brand is well recognised. It drivesdemand, supports premium pricing, attracts and retains talent, increases resilienceduring uncertainty, and provides confidence to investors. Despite this awareness,many organisations still struggle to quantify brand value or explain its role in businessperformance. This lack of clarity often creates a gap between marketing ambitionand financial decision-making, limiting the ability to invest for the long term. At Brand Finance, our mission for 30 years has been to close that gap. By bringingtogether robust valuation methodologies and in-depth research, we help leadersunderstand the financial impact of their brand and make better-informed decisions.Whether you are looking to strengthen brand performance, evaluate marketinginvestment, support a transaction, or bring greater alignment across yourorganisation, our team is here to help. As you explore this year’s findings, I encourage you to consider how the insightscan support clearer decision-making within your organisation. Strong brands arebuilt through informed choices and consistent investment, and our team is readyto help you translate the data into practical next steps for your strategy. SectorOverview SectorOverview China, accounting for 10%, continues tostrengthen its globa